Father-son dispute comes to settlement at Dong-A Pharm

Published: 2007-03-29 06:56:00

Updated: 2007-03-29 06:56:00

Dong-A Pharmaceutical held a special board of directors meeting on March 26 to discuss the selection of new directors, after Pharmaceutical Chairman Kang Shin-ho and his second son Moon-seok agreed to settle disputes over management control of the nation's largest drug maker on March 22.

Senior Kang agreed to let his son and his ally, former Dong-A president Yu Chung-sik, become members of t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.